课题基金 / 基金详情

One Step H. pylori Test--Screening and Individual Assays

One Step H. pylori Test--Screening and Individual Assays
幽门螺杆菌一步检测——筛查和个体化验
批准号:
6335517
负责人:
ROBERTA A SULK
金额:
$12.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2003-08-31

项目摘要

项目成果

ROBERTA A SULK的其他基金

相似基金

相关文献

中文摘要
翻译
这个项目的目的是证明四种不同类型的幽门螺杆菌检测的可行性。将开发针对幽门螺杆菌有机体及其抗体的检测方法。具体目标将是开发一种快速且非常低成本的检测方法,用于人群筛查和临床实验室。幽门螺杆菌是一种重要的癌症风险,因为它可以导致两种类型的恶性肿瘤:胃腺癌和原发胃MALT淋巴瘤。胃腺癌是全球癌症死亡的第二大原因,预计到2010年将成为所有死亡的第八大原因。提出的方法是一种表面增强拉曼免疫分析(SIIA),具有几个显著的优点。最重要的是,SERIA方法的表面局部增强消除了来自基质效应的光谱干扰。此外,它还消除了在其他免疫分析配置中产生生物危险废物和人员暴露的洗涤步骤。该项目将检查幽门螺杆菌血清的敏感性、选择性、保质期和生产成本。血清将用无菌缓冲溶液进行优化。一旦建立了典型的缓冲方案,我们将检查以小鼠组织、血液、粪便和胃液的形式提供的动物样本。当动物样本的优化建立后,我们将观察人类血液。组织、粪便和呕吐物样本。将与商业上可获得的试剂盒进行比较。拟议的商业应用:该项目的首要目标是生产一种针对幽门螺杆菌的微孔式检测方法。第二个是用于小批量检测的单一样本格式,第一个目标的市场是开放的,因为不存在大容量、低成本的程序。市场将是用于对大量人群进行幽门螺杆菌感染筛查的仪器和分析。
英文摘要
The aim of this project is to demonstrate feasibility of four different types of H. pylori assays. Assays will be developed for both the H. pylori organism and its antibody. The specific goal will be to develop a test which is rapid and very-low cost for screening of populations and for clinical laboratories. H. pylori is significant as a cancer risk as it can cause two types of malignancies: gastric adenocarcinoma and primary - gastric MALT lymphoma. The gastric adenocarcinoma is the second leading cause of cancer death around the world and it is expected by 2010 to be the eighth leading cause of all death. The method proposed is a Surface Enhanced Raman ImmunoAssay (SERIA) that has several significant advantages. Foremost, the surface localized enhancement of the SERIA method eliminates spectroscopic interference from matrix effects. Furthermore, it eliminates the need for washing steps that create biohazardous waste and personnel exposure in other immunoassays configurations. The project will examine sensitivity, selectivity, shelf-- life, and cost of production for H. pylori SERIA. The SERIA will be optimized with sterile buffer solutions. Once typical protocols are established with buffers we will examine animal samples supplied in the for of mice tissue, blood, feces, and gastric juices. When optimization with the animals samples has been established we will look at human blood. tissue, feces, and vomitus samples. Comparisons will made to commercially available kits. PROPOSED COMMERCIAL APPLICATIONS: The number one goal of this project is to produce a microwell format assay for H. pylori. Secondary is a single sample format for low-volume testing The market for the first goal is wide open as no high-volume low-cost procedure exists. The market would be instruments and assays for screening large populations for H pylori infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid Detection of Multiple Bioterrorism Agents
  • 批准号:
    6555367
  • 项目类别:
  • 资助金额:
    $10.11万
  • 财政年份:
    2002
  • 负责人:
    ROBERTA A SULK
  • 依托单位:
RAPID SCREENING OF HUMAN GROWTH HORMONE
  • 批准号:
    2865253
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    1999
  • 负责人:
    ROBERTA A SULK
  • 依托单位:
RAPID SCREENING OF HUMAN GROWTH HORMONE
  • 批准号:
    6293564
  • 项目类别:
  • 资助金额:
    $27.88万
  • 财政年份:
    1999
  • 负责人:
    ROBERTA A SULK
  • 依托单位:
LOW RISK ILLICIT DRUG LEVEL MONITORING
  • 批准号:
    6551220
  • 项目类别:
  • 资助金额:
    $34.1万
  • 财政年份:
    1999
  • 负责人:
    ROBERTA A SULK
  • 依托单位:
海外基金